Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

56.84 +3.96 (+7.49%)
Streaming Delayed Price Updated: 10:02 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Twist Bioscience Addresses Misleading Short-Seller Report
From Twist Bioscience Corporation
Via Business Wire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Twist Bioscience Corporation (TWST) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Twist Bioscience Corporation (TWST) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Twist Bioscience Corporation (TWST) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Twist Bioscience Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on Friday, November 18, 2022
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Promotes Patrick Finn, Ph.D., to President and Chief Operating Officer
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Human Sample ID Kit to Track Whole Blood Samples Through Lab Testing Workflow
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Earns 2022 Great Place to Work Certification
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at JSNN NanoImpacts 2022
From Twist Bioscience Corporation
Via Business Wire
News headline image
The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Baird 2022 Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Flash Memory Summit
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity
From Twist Bioscience Corporation
Via Business Wire
News headline image
DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow
From DNAnexus, Inc.
Via Business Wire
News headline image
Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.